key: cord-0762044-v2gxudy3
authors: Diep, Phuoc-Tan
title: Is there an underlying link between COVID-19, ACE2, oxytocin and vitamin D?
date: 2020-11-11
journal: Med Hypotheses
DOI: 10.1016/j.mehy.2020.110360
sha: 5c49053da7a15e5640d51ad64ce5d39002408f3e
doc_id: 762044
cord_uid: v2gxudy3

nan

I would like to link three papers recently published in your journal with regard to COVID-19. First, Gan et al. focus on angiotensin converting enzyme 2 (ACE2). They put forward the hypothesis that COVID-19 is an "ACE2 deficiency disorder, with ACE2 related multi-organ cell loss" (1). Second, Soumier and Sirigu propose oxytocin as a defence against COVID-19 because of its immune modulating properties and other auxiliary mechanisms (2) . Third, Silberstein brings to light a possible treatment for COVID-19 proposing the use of vitamin D to modulate the cytokine storm (3). At first glance, these three disparate papers have no observable link apart from COVID-19. Are COVID-19, ACE2, oxytocin and vitamin D enigmatically entangled? What of Occam's razor; is there a single unifying link? Yes, I believe there is: the oxytocin producing neurone. It is known that oxytocin is produced in the hypothalamus and transported to the pituitary gland where it is released systemically. ACE2 and transmembrane serine protease 2 (TMPRSS2) are thought to be required for SARS-CoV-2 cell entry. Both ACE2 and TMPRSS2 have been identified in the hypothalamus (4) and ACE2 has been located directly on the oxytocin neurone (5) . The vitamin D receptor has also been localised to oxytocin neurones, and there is data to suggest that vitamin D can increase oxytocin levels (6) . I would conclude with this hypothesis: hypothalamic oxytocin neurones could be infected by SARS-CoV-2, via ACE2 and TMPRSS2, leading to neuronal dysfunction or death with subsequent reduction in oxytocin production. In addition, oxytocin production may be limited by vitamin D deficiency. The reduction in plasma oxytocin could increase COVID-19 severity and be part of the "long COVID" phenomenon. Therefore I would reiterate the need for further research into the proposed use of oxytocin for COVID-19.

Sommerfeld COVID-19 as a viral functional ACE2 deficiency disorder with ACE2 related multi-organ disease Med Hypotheses

Sirigu Oxytocin as a potential defence against Covid-19? Med Hypotheses

Silberstein Vitamin D: A simpler alternative to tocilizumab for trial in COVID-19? Med Hypotheses

The hypothalamus as a hub for SARS-CoV-2 brain infection and pathogenesis bioRxiv 2020

Endocrine Significance of SARS-CoV-2's Reliance on ACE2 Endocrinology

Ames Vitamin D hormone regulates serotonin synthesis. Part 1: relevance for autism